Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Abstract Background Low-dose post-transplant cyclophosphamide (PTCy) in conjunction with anti-thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease (GVHD) prevention strategy in haploidentical hematopoietic cell transplant (haplo-HCT). Our study aims to assess the eff...

Full description

Bibliographic Details
Main Authors: Yu Wang, De-Pei Wu, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Wen-Jing Yu, Yang Xu, Fen Huang, Xiao-Jun Huang
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Journal of Hematology & Oncology
Subjects:
Anti-thymocyte globulin
Post-transplant cyclophosphamide
Low-dose
Haploidentical
Graft-versus-host disease
Online Access:http://link.springer.com/article/10.1186/s13045-019-0781-y

Internet

http://link.springer.com/article/10.1186/s13045-019-0781-y

Similar Items